Sep 2026· Physics and Imaging in Radiation Oncology· Vol 41, pp. 101082· 0 citations· 37 references
Medicine
TL;DR
Two deep learning dose prediction-driven workflows could generate a clinically acceptable plan in less than ten minutes for same-day, single-fraction treatment of a tumour in the lung.
Abstract
Background and Purpose Same-day, single-fraction radiotherapy requires efficient planning. We introduce two deep learning (DL) dose prediction-driven workflows to generate clinically acceptable plans for treating metastases in the lung. Materials and methods Consecutive patients treated for a tumour in the lung (11/2018–11/2024) were considered. One workflow used the computed tomography density map and a synthetic dose built from the tumour segmentation as inputs for the DL model [without-organs of interest (OOI)]. The other workflow additionally used predicted OOI segmentations (with-OOI). Optimisation objectives were extracted from the predicted dose by the treatment planning system (TPS). Generated plans were compared with clinical plans with the number of achieved goals, conformity index CI100, and control point modulation complexity score (cpMCS). Plan complexity increases with decreasing cpMCS. Processing times were recorded. Results Training and testing datasets contained 200 and 56 treatments, respectively. Without- / with-OOI workflows generated plans in 8.8 and 9.6 min. The 3%/3 mm gamma passing rates between predicted and clinical doses were median ± interquartile range 99.4 ± 0.7% / 99.3 ± 0.8%. After dose optimisation in the TPS, 25% of plans had a higher number of achieved clinical goals relative to clinical plans in both workflows. The conformity was improved (CI100 = −5.3% / −3.9% relative to the clinical value, p-values <0.001) at the cost of increased complexity (cpMCS = −19.4% / −19.0%, p-values <0.001). Conclusions Workflows driven by DL dose prediction could generate a clinically acceptable plan in less than ten minutes for same-day, single-fraction treatment of a tumour in the lung.
Abstract Background Radiation therapy treatment planning is a time‐consuming trial‐and‐error process, and the plan quality is heavily dependent on planners' experiences, resulting in a strong demand for automated planning methods that can rapidly generate uniformly high‐quality plans. Purpose This study aimed to develo...
Hai-Yan Jiang, Zeng-Tai Yuan, Zi-Hao Liu et al.· Journal of Applied Clinical...· 0 citations
Background and purpose This study presents a novel workflow for automated gross tumor volume (GTV) adaptation in online adaptive magnetic resonance imaging (MRI)-guided radiotherapy using promptable segmentation foundation models and evaluates its impact on the quality of adapted treatment plans. Materials and methods...
D. Dudás, T. Blöcker, Miguel Palacios et al.· Physics and Imaging in Radia...· 0 citations
PURPOSE
This study explores the feasibility of applying DL-based robustly optimized intensity modulated proton therapy (IMPT) planning in patients with oropharyngeal carcinoma (OPC) at an external center.
MATERIALS AND METHODS
A U-Net deep learning model was trained to predict dose distributions for robust IMPT plans...
I. V. van Bruggen, Anne Lisa Wolf, M. Kroesen et al.· Radiotherapy and Oncology· 0 citations
3D U-Net provided the most favorable overall performance among the evaluated architectures for intact-cervix cases and support further physician-supervised implementation, followed by multicenter external validation and cohort-level dosimetric assessment.
Chen-Ying Ma, Yi Fu, Lu Zhang et al.· Frontiers in Oncology· 0 citations
Dose-PlanNet, a physics-guided 3D deep learning architecture designed to predict dose distributions, is introduced, which demonstrates that physics-informed deep learning can accelerate radiotherapy workflows while safely maintaining the stringent dosimetric quality required for high-precision clinical deployment.
Ankit Bhattacharjee, Sougata Maity, S. Chakraborty et al.· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.